Finance

Lists
DVAI34:BVMF
Davita Inc BDR
893,56 BRL
0,00%
(0,00) 1D
9-окт., 16:56:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for DVAI34...
Open
893,56 BRL
High
893,56 BRL
Low
893,56 BRL
Mkt. cap
11,44 млд
Avg. vol.
7,00
Volume
1,00
52-wk high
1 253,26 BRL
52-wk low
546,63 BRL
Shares outstanding
63,80 млн
No. of employees
78 миң
Open
893,56 BRL
High
893,56 BRL
Low
893,56 BRL
Mkt. cap
11,44 млд
Avg. vol.
7,00
Volume
1,00
52-wk high
1 253,26 BRL
52-wk low
546,63 BRL
Shares outstanding
63,80 млн
No. of employees
78 миң
News stories
From web sources and news partners
Profile
DaVita Inc. is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients, and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation. In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the 2026 Fortune 500. Wikipedia
About Davita Inc BDR
CEOJavier J. Rodriguez
Employees78 миң
Founded1992
HeadquartersДенвер, Колорадо, Америка Кошмо Штаттары
SectorHealth care provider
Websitedavita.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
3,42 млд
3,62 млд
3,42 млд
3,55 млд
Cost of goods sold
2,33 млд
2,41 млд
2,34 млд
2,39 млд
Cost of revenue
2,33 млд
2,41 млд
2,34 млд
2,39 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
402,67 млн
472,36 млн
421,91 млн
423,46 млн
Operating expense
580,16 млн
659,06 млн
599,74 млн
591,27 млн
Total operating expenses
2,91 млд
3,07 млд
2,94 млд
2,98 млд
Operating income
507,30 млн
551,20 млн
473,55 млн
570,82 млн
Other non operating income
-17,26 млн
-21,03 млн
639,00 миң
4,47 млн
EBT including unusual items
308,80 млн
382,76 млн
341,23 млн
435,01 млн
EBT excluding unusual items
351,55 млн
391,79 млн
341,23 млн
437,04 млн
Income tax expense
68,55 млн
76,73 млн
66,20 млн
91,79 млн
Effective tax rate
22,20%
20,05%
19,40%
21,10%
Other operating expenses
-
-
-
-
Net income
150,33 млн
234,22 млн
197,53 млн
265,40 млн
Net profit margin
4,40%
6,47%
5,78%
7,47%
Earnings per share
2,51
3,40
2,87
4,02
Interest and investment income
-
-
-
-
Interest expense
-148,66 млн
-148,25 млн
-141,30 млн
-146,42 млн
Net interest expenses
-148,66 млн
-148,25 млн
-141,30 млн
-146,42 млн
Depreciation and amortization charges
177,49 млн
186,70 млн
177,83 млн
167,81 млн
EBITDA
684,80 млн
737,91 млн
651,38 млн
738,62 млн
Gain or loss from assets sale
-
-17,55 млн
-
-
AI content may include mistakes. Learn more
Google колдонмолору